The Challenge
To comply with a CAPA mandate, a large biotechnology company needed to unify sample data across closed and ongoing studies. Data was fragmented across 24+ vendors with no centralized oversight, driving gaps, inconsistencies, and rising operational risk.
The Solution
QuartzBio’s Sample Intelligence Solution was deployed as a unified data foundation with automated ingestion pipelines across all 24 vendors. AI-driven workflows enabled real-time harmonization, monitoring, and gap detection over a centralized, findable data asset.
The Outcomes
The CAPA was resolved by delivering a cross- functional single source of truth spanning 1M+ samples, with proactive detection of data gaps and vendor inconsistencies. The result was major cost avoidance (~$1M manual, >$5M regulatory) and a future-ready, automated data ecosystem.
